FDA DEVICE FACTS
DeepView AI® System
Spectralmd, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The DeepView AI®-Burn software analyzes images obtained using the DeepView AI® System, using artificial intelligence to detect deep burn tissue (deep partial thickness and full thickness) and provides segmentation of specific areas in a burn wound by highlighting areas that are unlikely to heal within 21 days with conservative treatment alone. The absence of a highlighted region on an image indicates the absence of deep burn tissue. The system will calculate wound area measurement and percent total body surface area (TBSA) burn. DeepView AI® System with AI®-Burn software is an aid to physicians in the management of thermal burn wounds and considering various treatment plans. The DeepView AI® System should be used in conjunction with clinical assessment and not as a stand-alone diagnostic device. The device's segmentation contour does not provide definitive delineation of the deep burn margin for precise excision sizing or delineating the precise borders of non-healing tissue.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。